136 related articles for article (PubMed ID: 17786860)
1. Neurokinin 1 receptor antagonists--current prospects.
Alvaro G; Di Fabio R
Curr Opin Drug Discov Devel; 2007 Sep; 10(5):613-21. PubMed ID: 17786860
[TBL] [Abstract][Full Text] [Related]
2. Potential therapeutic targets for neurokinin-1 receptor antagonists.
Duffy RA
Expert Opin Emerg Drugs; 2004 May; 9(1):9-21. PubMed ID: 15155133
[TBL] [Abstract][Full Text] [Related]
3. The role of neurokinin-1 receptor antagonists for the management of postoperative nausea and vomiting.
Apfel CC; Malhotra A; Leslie JB
Curr Opin Anaesthesiol; 2008 Aug; 21(4):427-32. PubMed ID: 18660647
[TBL] [Abstract][Full Text] [Related]
4. Neurokinin-1 receptor antagonists: a comprehensive patent survey.
Huang SC; Korlipara VL
Expert Opin Ther Pat; 2010 Aug; 20(8):1019-45. PubMed ID: 20533894
[TBL] [Abstract][Full Text] [Related]
5. The role of substance P in stress and anxiety responses.
Ebner K; Singewald N
Amino Acids; 2006 Oct; 31(3):251-72. PubMed ID: 16820980
[TBL] [Abstract][Full Text] [Related]
6. [Neurokinin 1 receptor antagonists--between hope and disappointment].
Rost K; Fleischer F; Nieber K
Med Monatsschr Pharm; 2006 Jun; 29(6):200-5. PubMed ID: 16792196
[TBL] [Abstract][Full Text] [Related]
7. Discovery and biological characterization of (2R,4S)-1'-acetyl-N-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl}-2-(4-fluoro-2-methylphenyl)-N-methyl-4,4'-bipiperidine-1-carboxamide as a new potent and selective neurokinin 1 (NK1) receptor antagonist clinical candidate.
Di Fabio R; Alvaro G; Griffante C; Pizzi DA; Donati D; Mattioli M; Cimarosti Z; Guercio G; Marchioro C; Provera S; Zonzini L; Montanari D; Melotto S; Gerrard PA; Trist DG; Ratti E; Corsi M
J Med Chem; 2011 Feb; 54(4):1071-9. PubMed ID: 21229983
[TBL] [Abstract][Full Text] [Related]
8. Discovery and stereoselective synthesis of the novel isochroman neurokinin-1 receptor antagonist 'CJ-17,493'.
Shishido Y; Wakabayashi H; Koike H; Ueno N; Nukui S; Yamagishi T; Murata Y; Naganeo F; Mizutani M; Shimada K; Fujiwara Y; Sakakibara A; Suga O; Kusano R; Ueda S; Kanai Y; Tsuchiya M; Satake K
Bioorg Med Chem; 2008 Aug; 16(15):7193-205. PubMed ID: 18640044
[TBL] [Abstract][Full Text] [Related]
9. Casopitant, a neurokinin-1 receptor antagonist with anti-emetic and anti-nausea activities.
Navari RM
Curr Opin Investig Drugs; 2008 Jul; 9(7):774-85. PubMed ID: 18600583
[TBL] [Abstract][Full Text] [Related]
10. Antagonists at the neurokinin receptors--recent patent literature.
Giardina GA; Gagliardi S; Martinelli M
IDrugs; 2003 Aug; 6(8):758-72. PubMed ID: 12917772
[TBL] [Abstract][Full Text] [Related]
11. Elucidating the antidepressant actions of substance P (NK1 receptor) antagonists.
Rupniak NM
Curr Opin Investig Drugs; 2002 Feb; 3(2):257-61. PubMed ID: 12020057
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of nausea and vomiting. Aprepitant, the first therapeutic acting NK-1 receptor antagonist].
Nieber K; Schoppmeyer K
Pharm Unserer Zeit; 2007; 36(5):373-80. PubMed ID: 17722144
[No Abstract] [Full Text] [Related]
13. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K
Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning, mutations and effects of NK1 receptor antagonists reveal the human-like pharmacology of gerbil NK1 receptors.
Engberg S; Ahlstedt I; Leffler A; Lindström E; Kristensson E; Svensson A; Påhlman I; Johansson A; Drmota T; von Mentzer B
Biochem Pharmacol; 2007 Jan; 73(2):259-69. PubMed ID: 17097619
[TBL] [Abstract][Full Text] [Related]
15. Neurokinin receptor modulation of respiratory activity in the rabbit.
Bongianni F; Mutolo D; Cinelli E; Pantaleo T
Eur J Neurosci; 2008 Jun; 27(12):3233-43. PubMed ID: 18554294
[TBL] [Abstract][Full Text] [Related]
16. The neurokinin-1 antagonist activity of maropitant, an antiemetic drug for dogs, in a gerbil model.
de la Puente-Redondo V; Tingley FD; Schneider RP; Hickman MA
J Vet Pharmacol Ther; 2007 Aug; 30(4):281-7. PubMed ID: 17610400
[TBL] [Abstract][Full Text] [Related]
17. Novel lactam NK1 antagonists with anti-emetic activity.
Hollingworth GJ; Carlson EJ; Castro JL; Chicchi GG; Clark N; Cooper LC; Dirat O; Salvo JD; Elliott JM; Kilburn R; Kurtz MM; Rycroft W; Tattersall FD; Tsao KL; Swain CJ
Bioorg Med Chem Lett; 2006 Mar; 16(5):1197-201. PubMed ID: 16384700
[TBL] [Abstract][Full Text] [Related]
18. Substance P neurokinin 1 receptor activation within the dorsal raphe nucleus controls serotonin release in the mouse frontal cortex.
Guiard BP; Guilloux JP; Reperant C; Hunt SP; Toth M; Gardier AM
Mol Pharmacol; 2007 Dec; 72(6):1411-8. PubMed ID: 17890358
[TBL] [Abstract][Full Text] [Related]
19. Neurokinin 1 receptor antagonists: correlation between in vitro receptor interaction and in vivo efficacy.
Lindström E; von Mentzer B; Påhlman I; Ahlstedt I; Uvebrant A; Kristensson E; Martinsson R; Novén A; de Verdier J; Vauquelin G
J Pharmacol Exp Ther; 2007 Sep; 322(3):1286-93. PubMed ID: 17575073
[TBL] [Abstract][Full Text] [Related]
20. Neurokinin-1 receptor antagonists inhibit the recruitment of opioid-containing leukocytes and impair peripheral antinociception.
Rittner HL; Lux C; Labuz D; Mousa SA; Schäfer M; Stein C; Brack A
Anesthesiology; 2007 Dec; 107(6):1009-17. PubMed ID: 18043070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]